Arrowgrass Capital Partners (US)’s HYPERION THERAPEUTICS INC COM STK (DE) HPTX Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio HPTX Stock Details HPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-8,849	Closed	-$406K	–	611
2015 Q1	$406K	Buy	+8,849	New	+$265K	0.01%	366

Arrowgrass Capital Partners (US)'s HPTX Position: Q2 2015 in Review

Arrowgrass Capital Partners (US) sold out of HYPERION THERAPEUTICS INC COM STK (DE) (HPTX) in Q2 2015, closing a stake of 8,849 shares — an estimated $406K sold.

Arrowgrass Capital Partners (US) first reported a position in HPTX in Q1 2015 and held it in 1 quarter. The position peaked at $406K in Q1 2015. 0 funds tracked by Wall St. Rank hold HPTX as of Q2 2015.

Arrowgrass Capital Partners (US) reported no remaining HYPERION THERAPEUTICS INC COM STK (DE) position as of Q2 2015 after selling out during the quarter.
Arrowgrass Capital Partners (US) sold 8,849 HYPERION THERAPEUTICS INC COM STK (DE) shares in Q2 2015, an estimated $406K.
Arrowgrass Capital Partners (US) first reported a position in HYPERION THERAPEUTICS INC COM STK (DE) in Q1 2015 and held it in 1 quarter.
Arrowgrass Capital Partners (US)'s HYPERION THERAPEUTICS INC COM STK (DE) position peaked at $406K in Q1 2015.
0 funds tracked by Wall St. Rank held HYPERION THERAPEUTICS INC COM STK (DE) as of Q2 2015.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q2 2015, filed 14 Aug 2015.